Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: Clouseau who wrote (681)	7/30/2004 11:35:13 AM
From: tom pope	Respond to of 724

There is no volume in the stock - avg volume is something just north of 6k. What this means is that there is no institutional interest. That doesn't make it a bad investment, just that there is no potential large investor there to move the stock.

To: Clouseau who wrote (681)	7/30/2004 1:47:09 PM
From: richardred	Respond to of 724

Your not missing anything Dave. Albeit small, I did find it positive however the last acquisition seems a big winner for the company. There also might be some top talent from the AOT/FSH merger out there to replace a board member who passed on. Outlooks still looks positive going forward, but nothing to get to excited about. Might take FSH awhile to digest AOT before they are back on the acquisition trail again. RR

To: Clouseau who wrote (681)	9/2/2004 1:27:21 PM
From: richardred	Respond to of 724

NBSC bites the bullet. Why not settle now, especially when the next quarter will have non recurring charges from a cash payment to a key employee, let go. Interesting to see what the next quarter brings minus the charges. 09/02 11:43 DJ New Brunswick Scientific Reaches Commerce Dept Settlement WASHINGTON (Dow Jones)--New Brunswick Scientific Inc. (NBSC) said Thursday it paid a $51,000 civil penalty, without admitting or denyingwrongdoing, to settle claims with the U.S. Commerce Department over thecompany's alleged failures to comply with export-control requirements. The provider of research equipment and scientific instrumentspreviously had reserved an amount that covers the civil penalty, according toa filing with the Securities and Exchange Commission. New Brunswick Scientific earlier disclosed it was working informallywith the Commerce Department to settle charges the company may have failed tocomply with some export-control requirements in connection with equipmentsales to Asia. According to previous SEC filings, the federal agency could haveimposed civil penalties up to $176,000 in the case, though the company hassaid it accrued an amount "significantly lower" than that based on itsassessment of a likely settlement amount. New Brunswick Scientific, based in Edison, N.J., earlier said it wasnotified in June 2003 of the Commerce Department's claims.-By Shira Ovide; Dow Jones Newswires; 202-862-1356;shira.ovide@dowjones.com (END) Dow Jones Newswires